Bridgebio Pharma Stock Forecast

Buy or Hold candidate since Jun 22, 2026 Loss -0.42%

The Bridgebio Pharma Inc. stock price fell by -0.421% on the last day (Tuesday, 23rd Jun 2026) from $68.92 to $68.63. During the last trading day the stock fluctuated 2.75% from a day low at $68.03 to a day high of $69.90. The price has been going up and down for this period, and there has been a 1.87% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -81 thousand shares and in total, 2 million shares were bought and sold for approximately $164.64 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.10% during the next 3 months and, with a 90% probability hold a price between $55.01 and $63.18 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

BBIO Signals & Forecast

The Bridgebio Pharma Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $67.52 and $67.31. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 7.44%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Bridgebio Pharma Inc. stock

Bridgebio Pharma Inc. finds support from accumulated volume at $67.39 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $1.87 between high and low, or 2.75%. For the last week the stock has had daily average volatility of 3.83%.

Our recommended stop-loss: $65.39 (-4.73%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 14 days ago.)

Trading Expectations (BBIO) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Bridgebio Pharma Inc. to open at $68.85, and during the day (based on 14 day Average True Range), to move between $67.29 and $69.97, which gives a possible trading interval of +/-$2.69 (+/-3.99%) up or down from last closing price. If Bridgebio Pharma Inc. takes out the full calculated possible swing range there will be an estimated 3.99% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $69.66 (1.50%) than the support at $67.39 (1.81%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Bridgebio Pharma Inc. stock A Buy?

Bridgebio Pharma Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.476 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $68.85 ( 0.325%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk